Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07253480

Correlation of Diaphragm Shear-Wave Elastography With Transdiaphragmatic Pressure in Healthy Adults: a Feasibility Study

Changes in intrapleural pressure after lung volume reduction in Chronic Obstructive Pulmonary disease (COPD) patients can lead to complications, including an increased risk of pneumothorax. This procedure, intended to improve lung function, may disturb the pressure balance within the pleural space, potentially precipitating pneumothorax. Careful monitoring of intrapleural pressure could help predict patients at risk. However, intrapleural pressure can currently only be measured invasively. Diaphragm shear-wave elastography (SWE) has been shown to reflect transdiaphragmatic pressure during isovolumetric inspiratory efforts and ventilation against inspiratory loading, and therefore may serve as a non-invasive surrogate for intrapleural pressure. This project outlines a stepwise study plan to evaluate SWE as a tool for intrapleural pressure monitoring (Figure 1). The project only moves to the next phase is the study previous phase was achieved successfully. The current protocol involves the first phase: to validate diaphragm SWE against transdiaphragmatic pressure and assess measurement reliability for local ultrasound systems in healthy adults.This prospective, single-centre, observational validation study will include twelve healthy adult volunteers. During a single study session, participants will perform standardized inspiratory efforts while simultaneous measurements of diaphragm SWE, transdiaphragmatic pressure (via esophageal and gastric balloon catheters), and mouth pressures are obtained. These methods are routinely applied in physiological research and carry minimal risk. Apart from brief nasal or throat discomfort during catheter placement, no significant adverse effects are expected. By establishing the relationship between diaphragm SWE, transdiaphragmatic pressure, and mouth pressures, this study aims to provide the essential validation step for future clinical research in COPD patients following lung volume reduction.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Medical Centre Groningen

Groningen, Provincie Groningen, 9713GZ, Netherlands

About this study

Rationale:

Changes in intrapleural pressure after lung volume reduction in COPD patients may contribute to pneumothorax. Non-invasive monitoring of pleural pressure could help identify patients at risk. Diaphragm shear-wave elastography (SWE) has shown potential to reflect transdiaphragmatic pressure (Pdi), but has not yet been validated across ultrasound systems. This study aims to validate diaphragm SWE against gold-standard Pdi and mouth pressures in healthy volunteers before applying the technique in COPD patients.

Objective:

To validate diaphragm SWE as a non-invasive measure of inspiratory effort by assessing its correlation with transdiaphragmatic pressure (Pdi) and mouth pressure (PImax and submaximal inspiratory pressures). Secondary objectives are to determine feasibility and inter-rater reliability of SWE measurements.

Study design:

Prospective, single-centre, observational validation study.

Study population:

Twelve healthy adults aged 18-60 years, BMI 18-30 kg/m², without respiratory, neuromuscular or cardiothoracic disease.

Main study parameters/endpoints:

Participants will undergo simultaneous measurements of diaphragm SWE, transdiaphragmatic pressure (Pdi = Pga-Pes), and inspiratory mouth pressures (Pmo) at rest and during inspiratory efforts at 20%, 40%, and 60% of PImax. SWE will be performed twice by different operators to assess inter-rater reliability. The primary analysis will determine within-individual and overall correlations between SWE and Pdi.

  • Pearson correlation coefficient repeated-measures correlation coefficient between SWE and Pdi across inspiratory efforts.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness:

The study involves a single measurement session (~1-2 hours). Procedures include nasal insertion of esophageal and gastric balloon catheters, mouth pressure measurements, and diaphragm ultrasound. These are routinely used physiological techniques with mild, transient, discomfort (e.g., mild throat or nasal irritation). No therapeutic intervention or follow-up is required. Risks are considered negligible and proportionate to the scientific value of the validation.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18-60 years, BMI 18-30 kg/m²
  • No known respiratory, neuromuscular, or cardiothoracic disease
  • Able to perform inspiratory maneuvers and consent.

Exclusion criteria

  • Pregnancy
  • History of smoking (> 10 pack years)
  • Impaired swallowing, as well as esophageal diseases, or disorders at the level of the gastroesophageal sphincter

Treatment and study plan

shear wave elastography of the diaphragm

Diagnostic Test

Participants will undergo simultaneous measurements of diaphragm SWE, transdiaphragmatic pressure (Pdi = Pga-Pes), and inspiratory mouth pressures (Pmo) at rest and during inspiratory efforts at 20%, 40%, and 60% of PImax. SWE will be performed twice by different operators to assess inter-rater reliability. The primary analysis will determine within-individual and overall correlations between SWE and Pdi.

  • Pearson correlation coefficient repeated-measures correlation coefficient between SWE and Pdi across inspiratory efforts.

Primary outcomes

  1. - Pearson correlation coefficient repeated-measures correlation coefficient between SWE and Pdi across inspiratory efforts.

    Time frame: 1 hour

    Participants will undergo simultaneous measurements of diaphragm SWE, transdiaphragmatic pressure (Pdi = Pga-Pes), and inspiratory mouth pressures (Pmo) at rest and during inspiratory efforts at 20%, 40%, and 60% of PImax. SWE will be performed twice by different operators to assess inter-rater reliability. The primary analysis will determine within-individual and overall correlations between SWE and Pdi.

Study contacts

Contact information is provided by the study sponsor or research team.

Wytze S de Boer, MD

CONTACT

[email protected]

(+31)0646312031 ext. 31

Sponsors and collaborators

Lead sponsor

Isala

Other

Collaborators

  • University Medical Center Groningen

Registry information

Acronym: PLEASSURE 1

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Nov 28, 2025
Registry last updated
Dec 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.